An Act amending Title 40 (Insurance) of the Pennsylvania Consolidated Statutes, providing for prescription drug cost credits in health insurance; and imposing penalties.

Summary

HB 2226 updates Pennsylvania's Unfair Trade Practices and Consumer Protection Law by expanding the list of deceptive practices, such as false advertising and pyramid schemes. It also creates a mechanism for health insurers to give members credits toward prescription drug costs and establishes penalties for non‑compliance. The changes aim to protect consumers from misleading sales tactics and lower out‑of‑pocket drug expenses.

AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.

Topics

Share